SCHEMBL4863133

SCHEMBL4863133

CN(CC1=C(c2cccnc2)CCCC1)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.47
CHRNA4 P43681 2/20 0.47
MAPK1 P28482 2/20 0.46
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CYP11B1 P15538 3/20 0.43
CYP11B2 P19099 3/20 0.43
CYP19A1 P11511 2/20 0.43
CYP17A1 P05093 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 1/20 0.42
THRB P10828 1/20 0.42
CYP2C19 P33261 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
KDM4E B2RXH2 1/20 0.41
GBA1 P04062 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
G6PC1 P35575 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4860370 0.99 MAPK1 (0.46) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
SCHEMBL4868924 0.83 CHRNB4 (0.51) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
SCHEMBL4865408 0.82 CHRNB4 (0.50) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
SCHEMBL4865416 0.82 CHRNB4 (0.50) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL4866474 0.82 CHRNB4 (0.50) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
SCHEMBL4868858 0.82 CHRNB4 (0.50) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL4859963 0.81 CHRNB4 (0.49) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL4865268 0.81 CHRNB4 (0.49) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL4859958 0.81 CHRNB4 (0.49) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3
SCHEMBL4866507 0.80 CYP2A6 (0.50) CHRNB2CHRNA4MAPK1CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384961-B2 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants GRUENENTHAL GMBH (DE) 2008-06-10 US claimed
EP-1572653-B1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS GRUENENTHAL GMBH (DE) 2007-11-21 EP claimed
JP-2006523182-A 2006-10-12 JP claimed
US-20060025456-A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants GRUENENTHAL GMBH (DE) 2006-02-02 US claimed
EP-1572653-A1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS Grünenthal GmbH (DE) 2005-09-14 EP claimed
WO-2004063161-A1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS Grünenthal GmbH (DE) 2004-07-29 WO claimed
US-7384961-B2 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants GRUENENTHAL GMBH (DE) 2008-06-10 US disclosed
EP-1572653-B1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS GRUENENTHAL GMBH (DE) 2007-11-21 EP disclosed
US-20060025456-A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants GRUENENTHAL GMBH (DE) 2006-02-02 US disclosed
EP-1572653-A1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS Grünenthal GmbH (DE) 2005-09-14 EP disclosed
WO-2004063161-A1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS Grünenthal GmbH (DE) 2004-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025456-A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants OPRK1, OPRM1, HTR1A CHRNB2 256/4885CHRNA4 133/4885MAPK1 2104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.